NRX Pharmaceuticals, Inc. (NRXP)
4.445
+0.16
(+3.86%)
USD |
NASDAQ |
May 28, 16:00
4.45
0.00 (0.00%)
After-Hours: 16:58
NRX Pharmaceuticals EPS Diluted (Quarterly) : -0.0442 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IGC Pharma, Inc. | -0.0245 |
| Definium Therapeutics, Inc. | -0.7087 |
| Atai Beckley, Inc. | -0.0833 |
| Alto Neuroscience, Inc. | -0.7976 |
| LENZ Therapeutics, Inc. | -1.323 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.43M |
| Revenue (Quarterly) | 1.068M |
| Total Expenses (Quarterly) | 2.498M |
| Enterprise Value | 149.28M |
| Gross Profit Margin (Quarterly) | 25.47% |
| Profit Margin (Quarterly) | -133.9% |
| Earnings Yield | -28.75% |
| Normalized Earnings Yield | -16.06 |